Medartis posts solid growth in 2H25 but flags constrained near-term outlook
Medartis reported 2H25 group sales of CHF146.3m, essentially matching consensus. The company delivered full-year organic growth of 15.7% and reported growth of 12.0%, implying roughly 16% organic growth in the second half. Core 2H EBITDA missed consensus modestly, and operating free cash flow fell as the company increased investments in production …